Tumor-host interactions: the role of inflammation

被引:87
作者
Le Bitoux, Marie-Aude [1 ,2 ]
Stamenkovic, Ivan [1 ,2 ]
机构
[1] CHU Vaudois, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland
[2] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland
关键词
Carcinogenesis; Inflammation; Cytokines; Mediators; Tumor-associated macrophages; Lymphocytes;
D O I
10.1007/s00418-008-0527-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It is well established that interactions between tumor cells and the host tissue stroma play a key role in determining whether and how any given solid malignancy will develop. In most cases, tumor cells hijack stromal cell functions for their own benefit and ultimately dictate the rules of engagement to the host tissue microenvironment. However, the contribution of the different stromal cell components to tumor growth remains to be clarified. Because most solid tumors are accompanied by a local inflammatory response, it has long been thought that inflammation and carcinogenesis are related. If formal proof that cancer can be initiated by inflammation in the absence of exogenous carcinogens is still lacking, there is abundant evidence that the inflammatory response can play a central role in modulating tumor growth and progression. This review will discuss some of the mechanisms whereby inflammation can both enhance and inhibit tumor growth.
引用
收藏
页码:1079 / 1090
页数:12
相关论文
共 83 条
[1]   Flow Cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of Superficial Transitional cell carcinoma of bladder [J].
Agarwal, A ;
Verma, S ;
Burra, U ;
Murthy, NS ;
Mohanty, N ;
Saxena, S .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (06) :734-743
[2]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[3]   The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance [J].
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
IMMUNOLOGICAL REVIEWS, 2008, 222 :155-161
[4]   Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? [J].
Apte, Ron N. ;
Voronov, Elena .
IMMUNOLOGICAL REVIEWS, 2008, 222 :222-241
[5]   IL-1, IL-18, and IL-33 families of cytokines [J].
Arend, William P. ;
Palmer, Gaby ;
Gabay, Cem .
IMMUNOLOGICAL REVIEWS, 2008, 223 :20-38
[6]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   TNF-α in promotion and progression of cancer [J].
Balkwill, Frances .
CANCER AND METASTASIS REVIEWS, 2006, 25 (03) :409-416
[9]   A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development [J].
Bar, D ;
Apte, RN ;
Voronov, E ;
Dinarello, CA ;
Cohen, S .
FASEB JOURNAL, 2004, 18 (01) :161-163
[10]   Targeting selectins and selectin ligands in inflammation and cancer [J].
Barthel, Steven R. ;
Gavino, Jacyln D. ;
Descheny, Leyla ;
Dimitroff, Charles J. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (11) :1473-1491